Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Neurokinin antagonists in the pipeline at Schering-Plough

Dec. 23, 1997

Schering-Plough obtains rights to Claritin metabolite from Sepracor

Dec. 22, 1997

Vyrex's respiratory antioxidant shows potential as asthma therapy

Dec. 22, 1997

Patient enrollment completed for ARDS phase Ib trial

Dec. 18, 1997

Singulair available in Mexico for asthma

Dec. 17, 1997

Atopy associated with IL-4R mutation; findings support Immunex's development of soluble IL-4R

Dec. 15, 1997

Yamanouchi describes development of dual NK1/NK2 antagonist

Dec. 15, 1997

Long-term asthma therapy options compared in children

Dec. 15, 1997

Alza and Warner-Lambert sign distribution agreement for nasal decongestant OTC

Dec. 12, 1997

Periodontix and Child Health Corporation of America develop new CF Rx

Dec. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...